Asthma Canada Home
  • Get Help
    • Speak to an Expert
    • Check Your Asthma
    • Resources & Tools
    • Asthma Action Plans
    • Educational Webinars
    • Asthma Game for Kids
  • About Asthma
    • Understanding Asthma
    • Diagnosing Asthma
    • Living with Asthma
    • Controlling Asthma
    • Asthma Triggers
    • Severe Asthma
    • Children & Asthma
      • Educational Game for Kids
      • Resources for School
    • Allergies & Asthma
    • Wildfires & Asthma
    • Winter & Asthma
    • Vaccines & Asthma
    • A.C.T. on Asthma
  • About Us
    • Our Strategy
    • What We Do
      • Education
        • Asthma & Allergy HelpLine
      • Research
      • Advocacy
    • Our History
    • Our Staff
    • Our HelpLine Staff
    • Our Medical & Scientific Experts
    • Our Board of Directors
    • Our Annual Reports
    • Contact Us
  • Research
    • Our Research Strategy
    • Our Research Programme
    • Research Publications
  • News & Updates
  • Get Involved
    • Ways to Give
      • Make a Donation
      • Host a Fundraiser
      • Leave a Gift in Your Will
      • Gift of Securities
    • How Funding Helps
    • Corporate Partnerships
      • Our Partners
    • Share Your Story
      • Community Stories
    • Join ACMA
  • Donate
Health Canada approves Fasenra® (benralizumab injection) as an add-on treatment for relapsing or refractory eosinophilic granulomatosis with polyangiitis

Health Canada approves Fasenra® (benralizumab injection) as an add-on treatment for relapsing or refractory eosinophilic granulomatosis with polyangiitis

by Asthma Canada | News & Updates, Uncategorized

Republished from Astrazeneca Canada. New indication supported by the MANDARA trial, which showed 58% of patients achieved remission and 41% of patients fully stopped taking oral corticosteroids Mississauga, ON, July 21, 2025 – Health Canada has granted a Notice of...
Asthma Canada Partners with Sun Life to Advance Personalized Asthma Care in Canada

Asthma Canada Partners with Sun Life to Advance Personalized Asthma Care in Canada

by Pauric Keegan | News & Updates, Uncategorized

Driven by a shared vision, both organizations recognize the urgent need to empower individuals to take control of their lung health through education, expert guidance, and tailored services. This common goal is the foundation of a new partnership that aims to...
Mother of Nine-Year-Old Who Died from Asthma Attack Urges People with Asthma to Take Precautions During Wildfire Season

Mother of Nine-Year-Old Who Died from Asthma Attack Urges People with Asthma to Take Precautions During Wildfire Season

by Pauric Keegan | News & Updates, Uncategorized

Mother of Nine-Year-Old who Died from a Wildfire Smoke-Induced Asthma Attack Calls on People with Asthma to Take Extra Precautions During Wildfire Season ~6 Practical Steps to Keep Your Asthma Managed this Wildfire Season~ Toronto, June 12, 2024 – As threats of...

Latest Posts

  • Asthma Canada and CAAIF Award $150,000 in Asthma Research Funding
    In News & Updates
  • Halloween Asthma & Allergy TriggersBEWARE: 13 Asthma & Allergy Triggers Lurking This Halloween!
    In News & Updates
  • Little girl receiving vaccine from doctorAsthma Canada Urges People with Asthma to Stay Up to Date on Vaccinations Ahead of Cold & Flu Season
    In News & Updates
  • On World Lung Day Asthma Canada Calls for Action to Close the Equity Gap in Asthma Care in Canada
    In News & Updates
  • Helping Kids Learn, Play, and Feel Confident with AsthmaAsthma Canada Launches Free Educational Game for Kids Living with Asthma as “September Asthma Peak” Approaches
    In News & Updates

Instagram

A huge congratulations to Dr. Anne Ellis, Professo A huge congratulations to Dr. Anne Ellis, Professor in the Department of Medicine at Queen's University. Dr. Ellis is one of two recipients of our latest Innovation and Impact Grants, delivered in partnership with the Canadian Allergy, Asthma and Immunolology Foundation, providing up to $150,000 in asthma research funding. Allergic rhinitis affects up to 80% of people with asthma, and both conditions are linked to high levels of TSLP, an immune-activating protein. Dr. Ellis’ study will test whether tezepelumab, which blocks TSLP, can reduce nasal symptoms and inflammation in people with both asthma and allergic rhinitis. This work bridges basic immunology and clinical research, advancing Canada’s leadership in translational allergy research and providing critical insights to guide future clinical trial design in this population. Learn more about the grants, awardees, and future research opportunities here: link in story. @queensuniversity @queensuhealth @quartsci.el #asthma | #asthmaResearch | #research
A huge congratulations to Dr. Harissios Vliagoftis A huge congratulations to Dr. Harissios Vliagoftis, Professor in the Department of Medicine at the University of Alberta. Dr. Vliagoftis is one of two recipients of our latest Innovation and Impact Grants, delivered in partnership with the Canadian Allergy, Asthma and Immunology Foundation, providing up to $150,000 in asthma research funding. His research project, “Monocytes Orchestrate Airway Inflammation in Human Asthma,” will investigate the role of monocytes, which may be the first cells to arrive in the lungs during asthma flare-ups and recruit eosinophils, with the goal of identifying ways to block their accumulation and develop new treatments. Learn more about the grants, awardees, and future research opportunities here: link in story. #asthma | #research | @ualberta_dofm @ualberta | @ualbertascience @the_caaif
Si vous avez pris des CSO pendant 3 jours ou plus Si vous avez pris des CSO pendant 3 jours ou plus à au moins 2 reprises dans la dernière année, il se peut que votre asthme ne soit pas maîtrisé. En savoir plus www.raisethealarm.ca/fr-ca/
If you’ve taken 2 or more oral corticosteroid cour If you’ve taken 2 or more oral corticosteroid courses for 3 or more days in the past year, your asthma may not be controlled. Learn more www.raisethealarm.ca/en-ca/
Follow on Instagram

Helpful links

9

About Asthma

9

Get Help

9

Get Involved

9

FAQ

9

Resources

9

News & Updates

9

Careers & Volunteer Opportunities

Contact Us



124 Merton St. Unit 401 Toronto, ON M4S 2Z2



1-866-787-4050



info@asthma.ca

Charitable Registration Number:

89853-7048-RR0001

  • Follow
  • Follow
  • Follow
  • Follow

Subscribe 

Sign-up to have the latest asthma news and information delivered to your inbox.

Subscribe

2025 © All Rights Reserved | Media | Privacy | Terms of Use